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Abstract
Phenobarbital is a phenobarbiturate used as a sedative, anticonvulsant or hypnotic with the 
doses prescribed and can cause teratogenic effects. The goal of this study was to examine an 
alternative method for the recognition of the mechanism or the bimolecular potential changes in 
mice fetus caused by Phenobarbital using FTIR micro spectroscopy. The mice were injected with 
Phenobarbital (120 mg/Kg) on gestation day 9. Fetuses were dissected on day 15 of gestation 
and morphological and histological studies on the fetus were carried out. Sections (10 µm) of 
normal and Phenobarbital treated fetus brains and livers were used for FTIR measurement in 
the wave number region of 400- 4000 cm. The results were shown by 2 derivatization of spectra 
and also subtracting from control spectra. In liver, the intensity at 1054 cm, 1155 cm, 1353 
cm, 1453cm,1645 cm, 1622 cm, 2944 cm, 2913 cm and 2845 cm were shifted and increased. 
In the brain, the intensity at 879 cm, 911 cm, 955 cm, 1223 cm, 1256 cm, 1304 cm, 1360 cm, 
1453 cm, 1529 cm, 1636 cm, 2845 cm, 2915 cm and 2950 cm were increased and shifted. The 
most important changes of the fetus brain tissue are on the β structure of proteins due to the 
amide I bands at 1636 cm, while extensive effects on the DNA structure were obvious for the 
Phenobarbital treated liver tissues. As a conclusion, FTIR spectroscopy might well be assumed 
as a potentially powerful teratogenic measurement instrument with a unique ability to identify 
the modified bimolecular structures.
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Introduction
Teratogenic exposures can cause an embryo 
or fetus defects. Teratogenicity depends upon 
the ability of the agent to cross the placenta. 
The embryo is most susceptible to teratogenic 
agents during periods of rapid differentiation. 
(1, 2). The morphological type of abnormality 
depends on the developmental stage at which the 
drug reaches the fetus and may be drug-specific. 
Whereas obvious anatomical defects result from 
disturbed organogenesis during early pregnancy, 
more subtle functional changes may occur due to 
intrauterine exposure after the first trimester. This 
appears to be most likely in the nervous system 
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aimed to measure the possibility of FTIR- 
MSP application for the recognition and 
discrimination of teratogtenecity with respect 
to control during the fetus growth and its 
relationship with morphological variations.
Experimental
Tissue preparation
Adult mice (10-12 weeks) weighting 20 g 
were obtained from Razi institute, Iran. The 
mice were fed with a standard diet with water 
ad libitum and kept in a room with controlled 
light (12:12, dark: light), temperature (22±10 
C), relative humidity (40-50%) and ventilation 
(15 air changes per hour). They were allowed 
to adapt to their environment for 1 week prior 
to the experiments. The mice were randomly 
mated and for emphasis of pregnancy their 
vaginal plaque were assessed after mating. Then, 
they were separated as control (3 mice) and 
phenobarbital treated groups (3 mice) (120 mg/
Kg/day IP based on reference 19) on gestation 
day 9 of pregnancy. Pregnant mice were 
sacrificed and dissected on day 15 of gestation 
and morphological and histological studies on 
the fetus were carried out (20). Measurement 
of fetus weight accomplished by digital balance 
and Crown-Rump (C-R) lengths accomplished 
by coils was done.
Also, after tissue fixation with bouin 
fixative solution, fetus sections at a pre-defined 
thickness of 10 µm were performed. Slices 
were either thaw-mounted on a 1 mm thick KBr 
window for IR microscopy and were mounted 
on conventional glass slides for staining with 
haematoxylin (H) and eosin (E) for studying of 
abnormality in fetus by light microscopy.
FTIR micro spectroscopy
FTIR measurements were performed in the 
absorbance mode.WQF-510 Fourier transform 
spectrometer (Rayleigh Optics, China) was 
equipped with a KBr beam splitter and a 
DLaTGS (Deuterated Lanthanide Triglycine 
Sulphate) detector and use of KBr window for 
µMAX IR microscope (PIKE Technologies, 
USA). The spectra were scanned in the mid-IR 
range from 4000 to 400 cm with a resolution of 4 
cm. 100 scans were coded for each spectrum and 
because of this system᾽s continued histogenesis 
after the first trimester (3).
Phenobarbital is a phenobarbiturate used as 
a sedative, anticonvultant or hypnotic with the 
doses prescribed. The combined use of it with 
other antiepileptics especially diphenylhydantoin 
increase its teratogenic effects. Phenobarbiturate 
can cause malformations such as facial 
dysmorphism, fetal hydantoin syndrome, with 
small saddle nose, large mouth with no philtrum, 
synophrys, and deformed helix. The possible 
teratogenic effect of phenobarbital in the 
offspring of pregnant women in the dataset of the 
Hungarian Case-Control Surveillance System 
of Congenital Abnormalities was evaluated, and 
an association of oral phenobarbital treatment 
with a higher risk of structural birth defects, 
that is, congenital abnormalities (CAs) was not 
found. Several studies show that the stimulation 
of maternal immune system can decrease or 
prevent drug- induced embryonic abnormalities 
(4-10).
There are controversial results regarding 
the teratogenic effect of phenobarbital, but the 
FDA classified the fetal risk of phenobarbital 
in the pregnancy category D (There is positive 
evidence of human fetal risk, but the benefits of 
its use in pregnant women may be acceptable 
despite the risk) (11).
The spectroscopic study of biological 
cells and tissue is an active area of research 
with a primary goal being to explain how 
accurately FTIR can determine whether 
cells or tissue are cancerous or not. FTIR is 
a potential tool for noninvasive optical tissue 
diagnosis. In recent years, its application 
in biological studies and particularly 
clinical investigations related to malignancy 
and cancer detection using spectroscopy 
techniques has been increased by both the 
clinical and non-clinical researchers (12-14). 
Since tissue is microscopically heterogeneous, 
microspectroscopy is the sampling mode 
most capable of representing accurately tissue 
complexity in histopathologic determinations. 
The development of clinical protocols for the 
routine examination of tissue histology or 
localized tumors using IR microspectroscopic 
methods has not been possible due to several 
related issues (15-18). This study was 
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the spectra were ratio against the background 
spectrum. 
Data processing and analysis
The data were analyzed using routines of 
the Main FTOS IR software. The spectra were 
normalized after the baseline correction of the 
entire spectrum. The spectra were recorded from 
several sites on the liver and brain tissues of mice 
fetus sections and an average spectrum from the 
all spectra (30 spectra for control and 30 spectra 
for treated tissuess) was computed. Second order 
derivatives were also calculated. Calculation of 
the second derivatives enhanced spectral features 
and also compensates for baseline shifts. From 
normalized absorbance spectra various spectral 
parameters were calculated and plotted against 
the x and y pixel coordinates.
Statistics
The data from the fetus weight and the fetus 
C-R length were analyzed by using Graphpad 
Prism© software. The statistical results of 
the phenobarbital treated fetus weight with 
the control fetus weight were compared with 
Students t-test (p<0.01). Also, the statistical 
results of the phenobarbital treated fetus C-R 
with the control fetus C-R were compared with 
using Students t-test (p<0.01). Results were 
presented as mean± SD.
Results and Discussion
Morphologic studies
Figure 1 shows the H & E stained sections 
of a normal and phenobarbital treated mice 
fetus liver (A) and brain (B). Clearly, the size 
of phenobarbital treated fetus and especially its 
liver is larger than the normal fetus. Cleft palate 
and umbilical hernia were seen in Phenobarbital 
treated fetus (Figure 1 (A) & (B)). In this study, 
the C-R length of phenobarbital treated fetus 
was more than the normal fetus, but there wasn᾽t 
any significant difference between them (control 
group C-R mean, 10.54±0.76 and treated group 
C-R mean, 10.53±0.66) (p<0.01) (Figure 2 (A)). 
The weight of phenobarbital treated fetus was 
more than that of normal fetus and there was 
a significant difference between them (control 
group weight mean, 0.154±0.018 and treated 
group weight mean, 0.209±0.029) (p<0. 01) 
(Figure 2 (B)). 
FTIR studies to determine compositional, 
structural and dynamical changes in 
phenobarbital treated mice fetus liver 
In the present study, the effect of 
phenobarbital treatment at 120 mg/Kg/day 
dose on 9 day of pregnancy in mice fetus was 
investigated at molecular level by using FTIR 
Figure 1. Photomicrograph of H & E stained sections of mice fetus brain (A) and liver (B).
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breathing mode (1622 cm).
Moreover, the intensity and frequency of the 
amide II bands at around 1453cmand 1525cmin 
treated tissue were increased and shifted compared 
to control tissue, mainly owing to asymmetric 
methyl deformation and Stretching C=N, C=C, 
respectively. The intensity and frequency of 
the bands at around 1353 cmwas increased 
and shifted compared to control tissue, mainly 
owing to Stretching C-O, deformation C-H, 
deformation N-H, the intensity at 1300 cmwas 
shifted owing to Deformation N-H cytosine, the 
intensity at 1256 cm and 1219 cmwere reduced 
and shifted compared to control tissue in treated 
tissue PO asymmetric (phosphate I) (1256 cm) 
and PO asymmetric vibrations of nucleic acids 
when it is highly hydrogen-bonded Asymmetric 
microspectroscopy. Figures 3, 4, 5, 6 and 7 
illustrated the typical IR spectra, 2 derivative and 
also difference of the liver tissues spectra of mice 
fetus exposed to phenobarbital minus the control 
liver tissues spectra. The information contained 
in this IR absorption spectrum originates from 
many different types of biomolecules in the 
tissue, including proteins, lipids, carbohydrates, 
and nucleic acids.
The intensity and frequency of the amide I 
bands at around 1645 cmand 1622 cmin treated 
tissue were increased, shifted and also converted 
to one peak instead of two peaks compared to 
control tissue, mainly owing to the Amide I, 
C5 methylated cytosine, C=O, stretching C=C 
uracyl, NH2 (1645 cm) and peak of nucleic acids 
due to the base carbonyl stretching and ring 
Figure 2. The C-R length of mice fetus (A)(control group C-R mean, 10.54±0.76 and treated group C-R mean, 10.53±0.66), (p< 0.01).
The weight of mice fetus (B), (control group weight mean, 0.154±0.018 and treated group weight mean, 0.209±0.029), (p< 0.01).
Figure 3. Mid-infrared spectra of (solid line) and phenobarbital treated (dot line) liver sections in the 1800–600 cm wave number region. 
The spectra are baseline-corrected and normalized.
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FTIR studies to determine compositional, 
structural and dynamical changes in 
phenobarbital treated fetus brain 
Figures 8, 9, 10, 11 and 12 illustrated the 
typical IR spectra, 2 derivative and also the 
difference of brain tissues of mice fetus exposed 
to phenobarbital minus the control brain tissues.
The intensity and frequency of the amide I 
band at around 1636cm in treated tissue were 
increased and shifted compared to untreated 
tissue, mainly owing to the β-sheet structure of 
amide I. Also this band was converted to two 
bands in treated tissue. Moreover, the intensity 
and frequency of the amide II bands at around 
1453 cmand 1529 cmin treated tissue were 
increased and shifted compared to untreated 
tissue, mainly owing to Asymmetric methyl 
deformation and C=N adenine, cytosine, 
respectively. The intensity and frequency of the 
bands at around 1360 cm, 1304 cm, 1256 cm 
and 1223 cm in treated tissue were increased 
and shifted compared to untreated tissue, 
mainly owing to Stretching C-O, deformation 
C-H,deformation N-H (1360 cm), Amide 
III(1304 cm) PO asymmetric (phosphate I) 
(1256 cm) and PO2asymmetric (phosphate I) 
(1223 cm). The intensity of the absorption band 
at around 1058 cm due to 2-Methylmannoside, 
Oligosaccharide C-OH stretching band and 
Mannose & mannose-6-phosphate in treated 
tissue was gradually increased and shifted.
The absorption band in treated tissue at 
hydrogen-bonded phosphate stretching mode 
(1219 cm).
The absorption band at around 949 cm 
in treated tissue resulted from Symmetric 
stretching vibration of v1PO4  (phosphate of 
HA) was approximately disappeared. The 
intensity of Left-handed helix DNA (Z form) at 
841 cm , a band at 817 cm in the treated tissue, 
corresponding to Ring CH deformation were 
reduced. The absorption band at around 771 cm 
in treated tissue resulted from Guanine in a C3´ 
endo/syn conformation in the Z conformation of 
DNA was reduced and shifted in treated fetus. 
The absorption band at around 707 cm owing to 
the Out-of-plane bending vibrations was shifted 
and increased in treated fetus. A band at 1155 
cm in treated tissue, corresponding to the C-O 
stretching vibration was increased and shifted.
The absorption band at around 1711 cm due 
to C=O (the region of the bases) in treated tissue 
was disappeared. The intensity of the absorption 
band at around 1054 cm due to from phospholipid 
phosphate and partly from oligosaccharide 
C-OH bonds phosphate ester in treated tissue 
was gradually increased and shifted.
The intensities of the absorption bands near 
2944 cm (stretching C-H), 2913 cm and 2845 
cm (Stretching vibrations of CH2 and CH3 
of phospholipids, cholesterol and creatine) 
in treated tissue were increased and shifted 
compared to the untreated tissue. 
Figure 4. Mid-infrared spectra of normal (solid line) and phenobarbital treated (dot line) liver sections in the 3700–2600 cm wave 
number region. The spectra are baseline-corrected and normalized.
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Figure 5. Second derivative of mean FTIR spectra of normal (solid line) and Phenobarbital treated (dot line) liver sections in the 
1800–600 cm wave number region. The spectra are baseline-corrected and normalized.
Figure 6. Second derivative of mean FTIR spectra of normal (solid line) and Phenobarbital treated (dot line) liver sections in the 
3700–2600 cm wave number region. The spectra are baseline-corrected and normalized.
911 cm was increased and shifted owing to the 
Phosphodiester stretching bands region (for 
absorbance due to collagen and glycogen). The 
absorption band at around 955 cm in treated 
tissue resulted from Symmetric stretching 
vibration of v1 PO4 (phosphate of HA), and the 
intensity was increased and shifted compared 
to untreated tissue. The intensity of C3´ endo/
anti (A-form helix) conformation at 879 cmwas 
increased and shifted and the intensity of the 
ring CH deformation at 810 cmin treated tissue 
was reduced and shifted. The absorption band 
at around 771 cm in treated tissue resulted from 
Guanine in a C3´ endo/syn conformation in the 
Z conformation of DNA was reduced in treated 
fetus. The absorption bands at around 709 cm 
owing to the Out-of-plane bending vibrations 
was increased and shifted in treated fetus. A 
band at 1155 cm in treated tissue, corresponding 
to the C-O stretching vibration was increased 
and shifted.
The intensities of the absorption bands near 
2950 cm(stretching C-H), 2915 cm and 2845 
cm (Stretching vibrations of CH2 and CH3 
of phospholipids, cholesterol and creatine) 
in treated tissue were increased and shifted 
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compared to the control tissue.
Conclusion
The teratogenicity of Phenobarbital has 
been extensively presented in many references 
through the morphological and histological 
investigations. Studies on rodents exposed to 
anticonvulsants drugs have shown a widespread 
apoptotic neurodegeneration in the fetus 
brain (21). The exact molecular alterations 
of these defects have not yet been explained. 
Biospectroscopy is the main technique used 
for some decades to solve this problem. This 
technique has proven itself in the differential 
diagnosis of cancer from normal tissues at the 
molecular level (22). Here, by using the FTIR-
MSP, the result of precise investigation at the 
chemical bands of mice fetal tissue biomolecules 
and their alterations after exposure to a D category 
medication is presented for the first time. As 
shown in the result section, Phenobarbital induces 
lots of changes in the mouse fetus at molecular 
levels in both very important and critical tissues 
of brain and liver. The chemical characteristics 
and conformational features of almost all parts 
Figure 7. Difference FTIR spectra of Phenobarbital treated liver sections in the 3600–600 cm wave number region minus the spectra of 
normal liver sections.
Figure 8. Mid-infrared spectra of normal (solid line) and phenobarbital treated (dot line) brain sections in the 1800–600 cm wave number 
region. The spectra are baseline-corrected and normalized.
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of cells are altered dramatically from the lipid 
bilayer matrix of the cell membrane to the 
nucleus DNA. Their modifications will represent 
conformational changes in the proteins which 
will be presented as metabolism malfunction as 
well as the structural proteins to be presented 
in the histology malformation. In any case, the 
most important changes of the brain tissue is 
on the β structure of proteins due to the amide 
I bands being appeared in a lower frequencies 
specially at 1636 cm. This might be as a result 
of a looser protein structure, particularly to be 
important in the structural proteins. On the other 
hand, extensive effects on the DNA structural 
changes are obvious for the Phenobarbital treated 
liver tissues. Not only a significant alteration in 
the N-H band of the cytosine, but also the C-O 
and phosphate backbone of DNA represented 
Figure 9. Mid-infrared spectra of normal (solid line) and phenobarbital treated (dot line) brain sections in the 3700–2600 cm wave 
number region. The spectra are baseline-corrected and normalized.
Figure 10. Second derivative of mean FTIR spectra of normal (solid line) and Phenobarbital- treated (dot line) brain sections in the 
1800–600 cm wave number region.
FTIR Microspectroscopy in Phenobarbital treated Mice Fetus. 
129
Figure 11. Second derivative of mean FTIR spectra of normal (solid line) and Phenobarbital- treated (dot line) brain sections in the 
3700–2600 cm wave number region.
Figure 12. Difference of FTIR spectra of Phenobarbital treated brain sections in the 3600–600 cm wave number region from normal 
brain sections.
at 1155 cm and 1536 cm are dramatically 
affected. Although more detail and statistical 
power are needed to prove and elaborate on 
these findings, but with even these initial 
investigations, dramatic structural changes in 
the brain, and gene expression modifications 
in the liver of treated tissues are obvious as the 
result of Phenobarbital exposure to the mouse 
fetus. These findings might very much introduce 
a powerful tool for the teratogenic investigation 
on phenobarbial effects on fetus and its uses in 
pregnant women. FTIR can be assumed as a 
potentially useful technique in understanding 
fetus changes after using different drugs. More 
studies are ongoing and results will be published 
in the future. 
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